Dana Callow - PAREXEL International Presiding Independent Director

Mr. A. Dana Callow, Jr., is Presiding Independent Director of Parexel International Corporationrationration. Mr. Callow is the Presiding Director of the Board, Chairman of the Nominating and Corporationrationrate Governance Committee, and a member of the Audit and Finance Committee and the Human Resources Committee. Since January 1997, Mr. Callow has served as the Managing General Partner of Boston Millennia Partners, a VC firm. Since 1983, Mr. Callow has also served as a general partner of several Boston Capital Ventures limited partnerships. He is a member of the Board of Trustees of Tufts University and the Board of Overseers of Tufts University School of Medicine. He is also a member of the Board of Directors of the Tuck Center for Private Equity and Entrepreneurship at Dartmouth College and The Leukemia and Lymphoma Society.
Age: 63        
781 487-9900  http://www.parexel.com

Management Efficiency

The company has return on total asset (ROA) of 0.05 % which means that it generated profit of $0.05 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 0.15 % meaning that it created $0.15 on every $100 dollars invested by stockholders.
The company currently holds 671.5 M in liabilities with Debt to Equity (D/E) ratio of 105.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. PAREXEL International has Current Ratio of 1.42 which is within standard range for the sector.

Similar Executives

Showing few of many executives


Gregory NordenZoetis
David GreenwayVertex Pharmaceuticals Incorpor
Alfred GilmanRegeneron Pharmaceuticals
David BullockOrigin Agritech Limited
Ravi BhoothalingamDr Reddys Laboratories Ltd
Omkar GoswamiDr Reddys Laboratories Ltd
Ashok GangulyDr Reddys Laboratories Ltd
Laurie BrlasPerrigo Company Plc
Rolf ClassonPerrigo Company Plc
Alan GarberVertex Pharmaceuticals Incorpor
Shlomo YanaiPerrigo Company Plc
Shikha SharmaDr Reddys Laboratories Ltd
Robert ScullyZoetis
Sangeeta BhatiaVertex Pharmaceuticals Incorpor
Hans HaslerDr Reddys Laboratories Ltd
William DoyleZoetis
Huda ZoghbiRegeneron Pharmaceuticals
Michael TrimbleOrigin Agritech Limited
Herman MorrisPerrigo Company Plc
Theodore SamuelstoPerrigo Company Plc
Jacqualyn FousePerrigo Company Plc

Entity Summary

PAREXEL International Corporationration, a biopharmaceutical services company, offer clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology solutions and services for pharmaceutical, biotechnology, and medical device industries worldwide. PAREXEL International Corp (PRXL) is traded on NASDAQ in USA and employs 18,600 people.

PAREXEL International Leadership Team

Michelle Graham, Chief Human Resource Officer, Senior Vice President
Ulf Schneider, Chief Administrative Officer, Senior Vice President
Thomas Senderovitz, Senior Vice President - Clinical Research Services
Dana Callow, Presiding Independent Director
Emma Reeve, Interim CFO, Corporate Vice President Controller
Josef Rickenbach, Founder, Chairman and CEO
Patrick Fortune, Independent Director
Eduard Holdener, Independent Director
Simon Harford, CFO, Senior Vice President
Joshua Schultz, Senior Vice President-Worldwide Head of PAREXEL Access
Gadi Saarony, Senior Vice President - Clinical Research Services
Ellen Zane, Director, Member of Compensation Committee, Member of HR Committee, CEO of Tufts Medical Center and President of Tufts Medical Center
Christian Dreger, Senior Vice President - Parexel Access and Parexel Consulting
Xavier Flinois, President - Perceptive Informatics
Douglas Batt, Sr. VP, General Counsel and Secretary
Sybrand Pretorius, Senior Vice President Chief Scientific Officer
Maykin Ho, Director
Richard Love, Independent Director
Ronald Aldridge, Sr. Director, Investor Relations
Mark Goldberg, President COO
Roland Andersson, Senior Vice President - Clinical Research Services
Christopher Lindop, Independent Director
Ingo Bank, CFO and Sr. VP
David Godwin, Senior Vice President-Global Business

Stock Performance Indicators

Current Sentiment - PRXL

PAREXEL International Investor Sentiment

Most of Macroaxis users are at this time bullish on PAREXEL International Corp. What is your perspective on investing in PAREXEL International Corp? Are you bullish or bearish?
98% Bullish
2% Bearish

Currently Active Assets on Macroaxis

Purchased few shares of
few hours ago
Traded for 182.01
Purchased few shares of
few hours ago
Traded for 1345.02
Purchased over 40 shares of
few hours ago
Traded for 64.33
Purchased few shares of
few hours ago
Traded for 182.01
Purchased over 40 shares of
few hours ago
Traded for 75.55
See also Your Equity Center. Please also try Instant Ratings module to determine any equity ratings based on digital recommendations. macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Search macroaxis.com